Abstract

Vancomycin resistant enterococci (VRE) belong to the most common causes of nosocomial infections worldwide. It has been reported that use of the glycopeptide growth promoter avoparcin selected for a significant livestock-reservoir of VRE in many European countries, including Norway. However, although avoparcin was banned as a feed-additive in 1995, VRE have for unknown reasons consistently been reported in samples from Norwegian broilers. When avoparcin was banned, broiler-feed was supplemented with the polyether ionophore narasin in order to control the diseases coccidiosis and the frequent sequela necrotic enteritis. A potential link between transferrable vancomycin resistance and reduced susceptibility to narasin was recently reported. The use of narasin as a feed additive was abolished by the Norwegian broiler industry in 2016 and since then, broilers have been reared without in-feed antibacterial supplements. In this study, we demonstrate that all VRE isolates from Norwegian broilers collected in 2006–2014 displayed reduced susceptibility to narasin. Surveillance data collected two years after the narasin abolishment show a significant reduction in VRE, below the detection limit of the surveillance method, and a concurrent marked reduction in Enterococcus faecium with reduced susceptibility to narasin. The significant decline of E. faecium with reduced susceptibility to these antimicrobial compounds also coincided with an increased focus on cleaning and disinfection between broiler flocks. Furthermore, data from a controlled in vivo experiment using Ross 308 broilers indicate that the proportion of E. faecium with reduced susceptibility to narasin was heavily reduced in broilers fed a narasin-free diet compared to a diet supplemented with narasin. Our results are consistent with that the abolishment of this feed additive, possibly in combination with the increased focus on cleaning and disinfection, has had a substantial impact on the occurrence of VRE in the Norwegian broiler population.

Highlights

  • Enterococci are part of the intestinal microbiota of humans and animals, but they are a major cause of nosocomial infections worldwide [1]

  • This study summarizes the surveillance data collected for vancomycin resistant enterococci (VRE) and E. faecium with reduced susceptibility to narasin in the NORM-VET program in the years 2000–2018 and reports molecular detection of potential resistance mechanisms, confirming a strong correlation between vancomycin resistance and reduced susceptibility to narasin

  • Vancomycin resistance was detected in 3.5%, 5% and 0% of the E. faecium isolated by the traditional method from faeces in 2002, 2004, and 2006, respectively (Fig 1; S2 Table)

Read more

Summary

Introduction

Enterococci are part of the intestinal microbiota of humans and animals, but they are a major cause of nosocomial infections worldwide [1]. The strains of enterococci causing the majority of hospital acquired infections may differ from the strains most often isolated from animals [3, 4], genetically related vancomycin resistant enterococci (VRE) have been shown to colonize both animals and humans [3, 5, 6]. Transfer of vancomycin resistance can occur between isolates of animal origin and human clinical isolates, both in vitro and in vivo in humans and animals [7,8,9]. Interspecies transfer of vancomycin resistance between enterococci and other Gram-positive bacteria including staphylococci can occur [1, 10]. There is a concern regarding community reservoirs of VRE that can transfer to humans and complicate treatment of infections

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call